Loading...
XSHE002100
Market cap1.16bUSD
Jan 14, Last price  
6.24CNY
1D
2.30%
1Q
-3.85%
Jan 2017
-30.43%
IPO
233.69%
Name

Tecon Biology Co Ltd

Chart & Performance

D1W1MN
XSHE:002100 chart
P/E
—
P/S
0.45
EPS
—
Div Yield, %
6.11%
Shrs. gr., 5y
7.26%
Rev. gr., 5y
29.26%
Revenues
19.03b
+13.71%
282,292,443371,283,300420,401,275670,654,8851,068,392,2412,074,691,8832,369,046,0392,983,984,2233,327,313,3933,724,760,2324,014,627,1314,167,289,4104,444,138,1224,630,025,7385,273,032,3507,476,316,39211,986,808,94415,744,337,61716,731,607,63619,025,806,286
Net income
-1.36b
L
20,142,44527,471,83538,180,31448,342,75664,869,84798,446,426107,425,05676,887,427108,011,991169,797,437207,630,270245,793,190392,541,388407,149,786313,726,252644,486,7131,720,414,4610214,145,170-1,363,316,030
CFO
1.75b
+434.11%
28,921,47829,900,95856,710,34751,097,476131,729,8850192,834,195348,613,768282,804,99090,606,336484,605,659512,185,756316,051,716649,327,3290306,979,54201,532,960,475327,985,5061,751,811,265
Dividend
Jun 16, 20230.22 CNY/sh
Earnings
May 20, 2025

Profile

Tecon Biology Co.Ltd engages in the research, development, production, and sale of animal feed in China and internationally. The company offers chicken, pig, ruminant, aquatic, and other feed products; and protein feeds and edible oils, as well as breeds piglets and pigs, and processes and sells meat. It also produces soybean, sunflower, rapeseed, and cottonseed oils and meals. In addition, the company manufactures and sells veterinary biological products. Further, it offers loan, bill acceptance, trade financing, project financing, credit, and other financing guarantees, as well as provides commodity financing supervision services. The company was formerly known as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and changed its name to Tecon Biology Co.Ltd in June 2016. Tecon Biology Co.Ltd was founded in 1993 and is based in Urumqi, China.
URL
http://www.tcsw.com.cn
IPO date
Dec 26, 2006
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
19,025,806
13.71%
16,731,608
6.27%
Cost of revenue
20,163,585
15,756,142
Unusual Expense (Income)
NOPBT
(1,137,778)
975,465
NOPBT Margin
5.83%
Operating Taxes
23,459
21,696
Tax Rate
2.22%
NOPAT
(1,161,238)
953,769
Net income
(1,363,316)
-736.63%
214,145
 
Dividends
(520,339)
(260,852)
Dividend yield
4.40%
2.32%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,319,417
3,940,984
Long-term debt
1,951,215
3,738,069
Deferred revenue
143,286
86,060
Other long-term liabilities
1
Net debt
2,412,982
3,709,552
Cash flow
Cash from operating activities
1,751,811
327,986
CAPEX
(1,001,328)
Cash from investing activities
(774,995)
Cash from financing activities
1,633,616
FCF
1,975,090
(658,900)
Balance
Cash
2,822,017
3,969,501
Long term investments
35,634
Excess cash
1,906,360
3,132,921
Stockholders' equity
3,450,801
5,977,638
Invested Capital
11,059,388
13,977,508
ROIC
7.40%
ROCE
5.70%
EV
Common stock shares outstanding
1,349,818
1,354,339
Price
8.77
5.54%
8.31
-22.34%
Market cap
11,837,903
5.18%
11,254,559
-4.22%
EV
15,755,041
16,679,214
EBITDA
(323,747)
1,688,655
EV/EBITDA
9.88
Interest
245,539
242,994
Interest/NOPBT
24.91%